New pill takes aim at Cancer's DNA repair
NCT ID NCT05055609
First seen Nov 01, 2025 · Last updated May 03, 2026 · Updated 26 times
Summary
This early-stage trial tests an experimental pill called TRE-515 in people with advanced solid tumors that have not responded to standard treatments. The drug works by blocking a key enzyme cancer cells need to make DNA, potentially slowing tumor growth. The main goals are to find a safe dose and check for side effects, with about 94 participants expected.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ONCOLOGY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Carolina BioOncology Institute
RECRUITINGHuntersville, North Carolina, 28078, United States
Contact
Contact Phone: •••-•••-••••
-
UCLA
RECRUITINGSanta Monica, California, 90404, United States
Contact Phone: •••-•••-••••
Contact
Conditions
Explore the condition pages connected to this study.